Grade (G) 3-5 AE rates were similar or lower in pts who had not received prior A or T. As first-line therapy, eribulin in HER2- pts and eribulin + TRAS in HER2+ pts were effective and well tolerated, regardless of prior A or T tx. However, in HER2+ pts re...